Our unit has received the congratulations of a patient, after finishing his participation in a clinical trial in Parkinson’s disease. It reflects a human experience of the collaboration of different professionals, focused on patient’s care.
Historias relacionadas
21 de noviembre de 2023
Trial on LRRK2 mutation in Parkinson’s disease is about to be completed. Our Clinical Trials…
3 de junio de 2021
This study could improve the efficacy and safety of the products being evaluated to try…
22 de julio de 2020
The FDA has approved the use of sublingual apomorphine (KYNMOBI) in motor blocks, in Parkinson’s…
18 de julio de 2019
We have been selected to evaluate an innovative therapy in this terrible disease. We will…
20 de marzo de 2019
The UDIC will shortly begin a clinical trial to evaluate the subcutaneous administration of levodopa,…
14 de marzo de 2019
Our Unit participated in a Phase II clinical trial, with a monoclonal anti-amyloid in Alzheimer’s,…
1 de marzo de 2019
Our Unit has surpassed two centers from the United States in the randomization of patients…
14 de febrero de 2019
On February 7, 2019, at the Exchange Conference UIC (Universitat Internacional de Catalunya) and the…